Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: health – Page 161

Top 10 upcoming future technologies | trending technologies | 10 upcoming tech.

Future technologies are currently developing at an acclerated rate. Future technology ideas are being converted into real life at a very fast pace.

These Innovative techs will address global challenges and at the same time will make life simple on this planet. Let’s get started and have a look at the top technologies of the future | Emerging technologies.

#futuretechnologies #futuretech #futuristictechnologys #emergingtechnologies #technology #tech #besttechnology #besttech #newtechnology #cybersecurity #blockchain #emergingtech #futuretechnologyideas #besttechnologies #innovativetechs.

Chapters.
00:00 ✅ Intro.
00:23 ✅ 10. Genomics: Device to improve your health.
01:13 ✅ 09. New Energy Solutions for the benefit of our environment.
01:53 ✅ 08. Robotic Process Automation: Technology that automates jobs.
02:43 ✅ 07. Edge Computing to tackle limitations of cloud computing.
03:39 ✅ 06. Quantum Computing: Helping to stop the spread of diseases.
04:31 ✅ 05. Augmented reality and virtual reality: Now been employed for training.
05:05 ✅ 04. Blockchain: Delivers valuable security.
05:50 ✅ 03. Internet of things: So many things can connect to the internet and to one another.
06:40 ✅ 02. Cyber Security to improve security.
07:24 ✅ 01. 3D Printing: Used to create prototypesfuturistic technologybest future tech.

Here at Tech Buzzer, we ensure that you are continuously in touch with the latest update and aware of the foundation of the tech industry. Thank you for being with us. Please subscribe to our channel and enjoy the ride.

Continue reading “10 Upcoming Future Technologies: How They’ll Impact Your Life” | >

Researchers are studying hibernating Arctic ground squirrels with the goal of harnessing the benefits of this odd natural state to protect astronauts’ health on long-duration space missions.

Hibernation is not just sleep. In fact, it’s quite different from sleep. While we sleep, our brains fire up and become highly active; in hibernation, on the contrary, brain activity completely slows down. The body temperature of hibernating animals also drops, in some cases close to the freezing point, cells stop dividing and heart rate decreases to two beats per minute.

Read more | >

H5N1 avian flu has existed for a quarter century. Only rarely have human cases occurred, with no sustained transmission reported. But “we cannot assume that will remain the case,” WHO Director General Tedros Adhanom Ghebreyesus said at a news conference. New, frequent reports that the disease has crossed into small mammals like minks, otters, foxes, and sea lions are cause for alarm, given the species’ similarities with humans, he noted.

While the risk to people remains low, public health officials must prepare “to face outbreaks in humans, and be ready also to control them as soon as possible,” Dr. Sylvie Briand, director of Global Infectious Hazard Preparedness and Emergency Preparedness at the WHO, told Fortune.

Ghebreyesus cautioned against touching or collecting sick or dead animals, and encouraged those who encounter such to report them to local authorities. Countries must strengthen their avian flu surveillance in areas where humans and wild animals interact, he insisted. And public health officials must work with manufacturers to ensure that vaccines and antivirals are available for global use, he said.

Read more | >

Is Director of the Division of Research, Innovation and Ventures (DRIVe — https://drive.hhs.gov/) at the Biomedical Advanced Research and Development Authority (https://aspr.hhs.gov/AboutASPR/ProgramOffices/BARDA/Pages/default.aspx), a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.

Dr. Patel is committed to advancing high-impact science, building new products, and launching collaborative programs and initiatives with public and private organizations to advance human health and wellness. As the DRIVe Director, Dr. Patel leads a dynamic team built to tackle complex national health security threats by rapidly developing and deploying innovative technologies and approaches that draw from a broad range of disciplines.

Dr. Patel brings extensive experience in public-private partnerships to DRIVe. Prior to joining the DRIVe team, he served as the HHS Open Innovation Manager. In that role, he focused on advancing innovative policy and funding solutions to complex, long-standing problems in healthcare. During his tenure, he successfully built KidneyX, a public-private partnership to spur development of an artificial kidney, helped design and execute the Advancing American Kidney Health Initiative, designed to catalyze innovation, double the number of organs available for transplant, and shift the paradigm of kidney care to be patient-centric and preventative, and included a Presidential Executive Order signed in July 2019. He also created the largest public-facing open innovation program in the U.S. government with more than 190 competitions and $45 million in awards since 2011.

Prior to his tenure at HHS, Dr. Patel co-founded Omusono Labs, a 3D printing and prototyping services company based in Kampala, Uganda; served as a scientific analyst with Discovery Logic, (a Thomson Reuters company) a provider of systems, data, and analytics for real-time portfolio management; and was a Mirzayan Science and Technology Policy Fellow at The National Academies of Science, Engineering, and Medicine. He also served as a scientist at a nanotechnology startup, Kava Technology.

Dr. Patel holds a US patent issued in 2005 and has authored over a dozen peer-reviewed articles in areas such as nanotechnology, chemistry, innovation policy, and kidney health.

Dr. Patel earned his Ph.D. in physical chemistry from the Georgia Institute of Technology, and has a bachelor’s degree in chemistry from Washington University in St. Louis.

Continue reading “Dr. Sandeep Patel, Ph.D. — BARDA — Developing Effective Life-Saving Medical Countermeasures For All” | >

Dr. Renee Wegrzyn, Ph.D. is the inaugural director of the Advanced Research Projects Agency for Health (ARPA-H — https://arpa-h.gov/), an agency that supports the development of high-impact research to drive biomedical and health breakthroughs to deliver transformative, sustainable, and equitable health solutions for everyone. ARPA-H’s mission focuses on leveraging research advances for real world impact.

Previously, Dr. Wegrzyn served as a vice president of business development at Ginkgo Bioworks and head of Innovation at Concentric by Ginkgo, where she focused on applying synthetic biology to outpace infectious diseases—including Covid-19—through biomanufacturing, vaccine innovation and biosurveillance of pathogens at scale.

Prior to Ginkgo, Dr. Wegrzyn was program manager in the Biological Technologies Office at DARPA, where she leveraged the tools of synthetic biology and gene editing to enhance biosecurity, promote public health and support the domestic bioeconomy. Her DARPA portfolio included the Living Foundries: 1,000 Molecules, Safe Genes, Preemptive Expression of Protective Alleles and Response Elements and the Detect it with Gene Editing Technologies programs.

Dr. Wegrzyn received the Superior Public Service Medal for her work and contributions at DARPA. Prior to joining DARPA, she led technical teams in private industry in the areas of biosecurity, gene therapies, emerging infectious disease, neuromodulation, synthetic biology, as well as research and development teams commercializing multiplex immunoassays and peptide-based disease diagnostics.

Dr. Wegrzyn holds doctorate and bachelor’s degrees in applied biology from the Georgia Institute of Technology. She was a fellow in the Center for Health Security Emerging Leaders in Biosecurity Initiative and completed postdoctoral training as an Alexander von Humboldt fellow in Heidelberg, Germany.

Read more | >

What’s next?

Increasingly it seems there is nothing that ChatGPT cannot do, even consulting judges in cases and boosting research. Now, the AI chatbot has been found to score at or around the approximately 60 percent passing threshold for the United States Medical Licensing Exam (USMLE), “with responses that make coherent, internal sense and contain frequent insights.”

This is according to a study published on Thursday in the open-access journal PLOS Digital Health.

AndreyPopov/iStock.

Now, the AI chatbot has been found to score at or around the approximately 60 percent passing threshold for the United States Medical Licensing Exam (USMLE), “with responses that make coherent, internal sense and contain frequent insights.”

Read more | >

Scientists at the University of Connecticut Health, Yale University, and Johns Hopkins University have discovered that certain cancer cells possess the ability to evade limitations caused by oxygen deprivation, enabling the cancer cells to continue to grow.

The findings were recently published in the journal Cell Systems. The research was led by Kshitiz, an assistant professor in the Department of Biomedical Engineering, in collaboration with scientists Chi V. Dang from Johns Hopkins and Andre Levchenko from Yale.

Nearly a decade ago, the researchers observed a strange phenomenon while looking at cancer cells under hypoxia—or a lack of oxygen.

Read more | >

An excellent overview of the story of how the U.S. responded to the COVID-19 pandemic along with suggestions for ways to continue making strides in combatting SARS-CoV-2 as well as how we may prepare for future emerging pathogens. The article provides an interesting case study on mechanisms of large-scale human organization, examines ways that we have succeeded in managing so many moving pieces, and explores ways that we could do better in the future. #nih #health #medicine #government #biotechnology

Investment, collaboration, and coordination have been key.

Francis Collins [email protected], Stacey Adam, […], Christine Colvis, Elizabeth Desrosiers, […], Ruxandra Draghia-Akli, Anthony Fauci, Maria Freire, Gary Gibbons, Matthew Hall, […], Eric Hughes, Kathrin Jansen, Michael Kurilla, H. Clifford Lane, Douglas Lowy, Peter Marks, Joseph Menetski, William Pao, Eliseo Pérez-Stable, Lisa Purcell, Sarah Read, Joni Rutter, Michael Santos, Tara Schwetz, Jeffrey Shuren, Timothy Stenzel, Paul Stoffels, Lawrence Tabak, Karen Tountas, Bruce Tromberg, David Wholley, Janet Woodcock, and John Young +29 authors +27 authors +22 authors fewer Authors Info & Affiliations

Science.

Read more | >

A Quebec hospital adopts a novel use of VR to help patients with anxiety, phobias and pain.

In a newswire release today, the Fondation de l’Hôtel-Dieu d’Alma (the Alma Hospital Foundation) announced the launch of a virtual reality (VR) project aimed at improving the mental health of those experiencing increasing anxiety. The Alma Hospital is a regional health centre for the area of Lac St. Jean and the Saguenay River valley to the north of Quebec City.

Jean Lamoureux, the hospital’s Executive Director states, “The number of requests for mental-health consultations is estimated to have increased by 30 to 40 percent during the pandemic. These needs are urgent…and, thanks to the innovation of Paperplane Therapeutics and TELUS, we will transform the way health services are delivered, while having a significant positive impact on patient well-being through technology.”

Read more | >

Arizona State University has officially begun a new chapter in X-ray science with a newly commissioned, first-of-its-kind instrument that will help scientists see deeper into matter and living things. The device, called the compact X-ray light source (CXLS), marked a major milestone in its operations as ASU scientists generated its first X-rays on the night of Feb. 2.

“This marks the beginning of a new era of science with compact accelerator-based X‑ray sources,” said Robert Kaindl, who directs ASU’s Compact X-ray Free Electron Laser (CXFEL) Labs at the Biodesign Institute and is a professor in the Department of Physics. “The CXLS provides hard X-ray pulses with high flux, stability and ultrashort durations, in a very compact footprint. This way, matter can be resolved at its fundamental scales in space and time, enabling new discoveries across many fields — from next-generation materials for computing and information science, to renewable energy, biomolecular dynamics, drug discovery and human health.”

Building the compact X-ray light source is the first phase of a larger CXFEL project, which aims to build two instruments including a coherent X-ray laser. As the first-stage instrument, the ASU CXLS generates a high-flux beam of hard X‑rays, with wavelengths short enough to resolve the atomic structure of complex molecules. Moreover, its output is pulsed at extremely short durations of a few hundred femtoseconds — well below a millionth of one millionth of a second — and thus short enough to directly track the motions of atoms.

Read more | >